Hyperfine, Inc.
HYPRHyperfine, Inc. in brief
Hyperfine, Inc. is a listed company in the Medical Devices industry, based in Guilford, Connecticut, USA. Its market value was $78 M on 23 October 2026, which makes it the 19,682nd largest listed company in the world and the 3,655th largest in the USA on this site. In the year to December 2025 it had sales of $14 M and a net loss of $36 M. It employs about 102 people and Maria Sainz is its chief executive. Its shares trade under the symbol HYPR (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Hyperfine, Inc.
We are an innovative health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence-powered portable ultra-low-field magnetic resonance brain imaging. Our Swoop® Portable MR Imaging® System produces high-quality images at a significantly lower magnetic field strength than conventional magnetic resonance imaging scanners. Our Swoop® system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated patient-friendly experience, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop® system is a portable, ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. Healthcare professionals can use the Swoop® system to make effective clinical diagnoses and decisions in various care settings where conventional MRI devices are inaccessible and/or when they are not readily available. The portable design of our Swoop® system make it safely and readily accessible anywhere in a hospital, clinic, physician’s office, or patient care site and it does not require any special facilities accommodations. The easy to use, iPad-based interface makes its operation easy to learn and it does not require specialized personnel to operate safely. ULF MR does not expose patients to harmful ionizing radiation and compares favorably in this regard to X-ray computed tomography or positron emission tomography.
From the company's annual report filed with the US SEC: read the report
Hyperfine, Inc. timeline
- 2020
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2021
- 🔔Initial public offering as HealthCor Catalio Acquisition Corp.Final prospectus filed with the SEC on 28 January 2021; shares registered for exchange trading on 26 January 2021. The blank-check company later merged with the business that carries the name today.
- ✎Renamed Hyperfine, Inc.Formerly HealthCor Catalio Acquisition Corp..
- 2025
- 💰Record revenue of $14 millionFY2025, the highest of the 6 years on record.
Events of Hyperfine, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #4,621 (Dec 2022) · #3,556 (Jul 2023) · #3,855 (Jan 2024) · #1,929 (Mar 2026) · #3,446 (Aug 2026) · #3,588 (Oct 2026) · #3,659 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 4.1×
- Price / book
- 1.9×
- Free cash flow yield
- -37.6%
- Net margin (TTM)
- -156.6%
- Operating margin
- -273.5%
- Return on equity
- -72.7%
- Liabilities / assets
- 25.8%
- Net debt
- $-35M
- Revenue growth
- +5.2%
- R&D / revenue
- 128.7%
- Revenue per employee
- $133 K
- Profit per employee
- $-349 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $14M | +5.2% | $-37M | $-36M | -262.3% |
| Dec 2024 | $13M | +16.9% | $-43M | $-41M | -315.9% |
| Dec 2023 | $11M | +62.0% | $-48M | $-44M | -401.1% |
| Dec 2022 | $7M | +354.0% | $-74M | $-44M | -649.6% |
| Dec 2021 | $2M | +417.2% | $-65M | $-65M | -4323.3% |
| Dec 2020 | $0M | — | $-23M | $-23M | -8079.3% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-28M | $1M | $-29M | $-0.43 | — |
| Dec 2024 | $-39M | $0M | $-39M | $-0.56 | — |
| Dec 2023 | $-42M | $1M | $-43M | $-0.62 | — |
| Dec 2022 | $-72M | $1M | $-73M | $-1.04 | — |
| Dec 2021 | $-47M | $3M | $-50M | $-17.57 | — |
| Dec 2020 | $-22M | $2M | $-23M | $-15.38 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $6M (+73.3% on a year earlier), net income $-6M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 9, 202610-QQuarterly report · period to Sep 2026
- Nov 9, 20268-KCurrent reportResults of operations
- Oct 8, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Sep 18, 20268-KCurrent reportListing notice
- Aug 6, 202610-QQuarterly report · period to Jun 2026
- Aug 6, 20268-KCurrent reportResults of operations
- May 21, 20268-KCurrent reportShareholder vote
- May 12, 202610-QQuarterly report · period to Mar 2026
- May 12, 20268-KCurrent reportResults of operations
- Apr 8, 2026DEF 14AProxy statement
- Mar 18, 202610-KAnnual report · period to Dec 2025
- Mar 18, 20268-KCurrent reportMaterial agreement · New financial obligation · Unregistered share sale
Official filings of Hyperfine, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $14 M
- Operating income
- $-37 M
- Net income
- $-36 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $55 M
- Total liabilities
- $14 M
- Total equity
- $41 M
As of December-2025
Top 87 institutional investors in Hyperfine, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4,656,638 | -16,449 (-0.35%) | 4.17% | $4 M | Nov 13, 2026 |
| 2 | Vanguard Capital Management LLC | 3,380,087 | 0 (0.00%) | 3.03% | $3 M | Nov 13, 2026 |
| 3 | Geode Capital Management, LLC | 1,947,462 | -13,349 (-0.68%) | 1.74% | $2 M | Nov 6, 2026 |
| 4 | Fosun International Ltd | 1,742,020 | 0 (0.00%) | 1.56% | $1 M | Nov 10, 2026 |
| 5 | Catalio Capital Management, LP | 1,303,155 | -16,886 (-1.28%) | 1.17% | $1 M | Nov 16, 2026 |
| 6 | State Street Corp | 1,033,366 | +16,396 (+1.61%) | 0.93% | $1 M | Nov 12, 2026 |
| 7 | Alphabet Inc. | 898,720 | 0 (0.00%) | 0.80% | $1 M | Nov 6, 2026 |
| 8 | Renaissance Technologies LLC | 715,607 | -230,229 (-24.34%) | 0.64% | $1 M | Nov 12, 2026 |
| 9 | Northern Trust Corp | 637,102 | +4,048 (+0.64%) | 0.57% | $1 M | Nov 16, 2026 |
| 10 | Vanguard Fiduciary Trust Co | 630,622 | +63,513 (+11.20%) | 0.56% | $1 M | Nov 13, 2026 |
| 11 | Vanguard Portfolio Management LLC | 547,502 | +302 (+0.06%) | 0.49% | $0 M | Nov 13, 2026 |
| 12 | Russell Investments Group, Ltd. | 487,994 | +481,734 (+7695.43%) | 0.44% | $0 M | Nov 6, 2026 |
| 13 | Squarepoint Ops LLC | 379,152 | +355,777 (+1522.04%) | 0.34% | $0 M | Nov 9, 2026 |
| 14 | Citadel Advisors LLC | 347,058 | New | 0.31% | $0 M | Nov 16, 2026 |
| 15 | Isthmus Partners, LLC | 313,350 | 0 (0.00%) | 0.28% | $0 M | Oct 21, 2026 |
| 16 | Bank of New York Mellon Corp | 310,405 | 0 (0.00%) | 0.28% | $0 M | Nov 5, 2026 |
| 17 | Charles Schwab Investment Management Inc | 190,235 | 0 (0.00%) | 0.17% | $0 M | Nov 16, 2026 |
| 18 | Nuveen, LLC | 175,441 | +72,610 (+70.61%) | 0.16% | $0 M | Nov 10, 2026 |
| 19 | XTX Topco Ltd | 164,460 | +148,067 (+903.23%) | 0.15% | $0 M | Nov 16, 2026 |
| 20 | Two Sigma Investments, LP | 145,150 | -180,849 (-55.48%) | 0.13% | $0 M | Nov 16, 2026 |
| 21 | Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 127,725 | New | 0.11% | $0 M | Oct 27, 2026 |
| 22 | Bridgeway Capital Management, LLC | 126,814 | -1,586 (-1.24%) | 0.11% | $0 M | Nov 16, 2026 |
| 23 | Empowered Funds, LLC | 96,214 | New | 0.09% | $0 M | Nov 13, 2026 |
| 24 | Goldman Sachs Group Inc | 90,917 | +56,689 (+165.62%) | 0.08% | $0 M | Nov 16, 2026 |
| 25 | Cerity Partners LLC | 86,074 | +1,074 (+1.26%) | 0.08% | $0 M | Nov 13, 2026 |
Show all 87: investors 26 to 87
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Bank Of America Corp /de/ | 76,090 | +31,246 (+69.68%) | 0.07% | $0 M | Nov 16, 2026 |
| 27 | Tortoise Investment Management, LLC | 73,500 | +1,500 (+2.08%) | 0.07% | $0 M | Nov 6, 2026 |
| 28 | Deutsche Bank AG\ | 68,637 | -9,583 (-12.25%) | 0.06% | $0 M | Nov 6, 2026 |
| 29 | Rhumbline Advisers | 65,583 | +11,770 (+21.87%) | 0.06% | $0 M | Nov 10, 2026 |
| 30 | Price T Rowe Associates Inc /MD/ | 64,161 | 0 (0.00%) | 0.06% | $0 M | Nov 16, 2026 |
| 31 | Kathmere Capital Management, LLC | 51,813 | 0 (0.00%) | 0.05% | $0 M | Oct 20, 2026 |
| 32 | Invesco Ltd. | 51,557 | +9,022 (+21.21%) | 0.05% | $0 M | Nov 12, 2026 |
| 33 | PFS Partners, LLC | 50,000 | +30,000 (+150.00%) | 0.04% | $0 M | Oct 21, 2026 |
| 34 | Signaturefd, LLC | 49,098 | 0 (0.00%) | 0.04% | $0 M | Oct 23, 2026 |
| 35 | Morgan Stanley | 49,067 | +7,035 (+16.74%) | 0.04% | $0 M | Nov 13, 2026 |
| 36 | Procyon Advisors, LLC | 47,753 | 0 (0.00%) | 0.04% | $0 M | Oct 21, 2026 |
| 37 | AQR Capital Management LLC | 44,311 | New | 0.04% | $0 M | Nov 16, 2026 |
| 38 | UBS Group AG | 43,881 | +13,452 (+44.21%) | 0.04% | $0 M | Nov 10, 2026 |
| 39 | Jpmorgan Chase & Co | 43,581 | +4,627 (+11.88%) | 0.04% | $0 M | Nov 12, 2026 |
| 40 | Gsa Capital Partners LLP | 43,164 | New | 0.04% | $0 M | Nov 16, 2026 |
| 41 | Essential Planning, LLC. | 42,398 | 0 (0.00%) | 0.04% | $0 M | Oct 21, 2026 |
| 42 | Global Retirement Partners, LLC | 40,084 | +31,584 (+371.58%) | 0.04% | $0 M | Nov 10, 2026 |
| 43 | Sanctuary Advisors, LLC | 39,978 | +40 (+0.10%) | 0.04% | $0 M | Nov 13, 2026 |
| 44 | Susquehanna International Group, LLP | 38,376 | +10,231 (+36.35%) | 0.03% | $0 M | Nov 16, 2026 |
| 45 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 37,991 | +1,943 (+5.39%) | 0.03% | $0 M | Nov 16, 2026 |
| 46 | Signature Estate & Investment Advisors LLC | 35,474 | New | 0.03% | $0 M | Oct 13, 2026 |
| 47 | EP Wealth Advisors, LLC | 34,725 | 0 (0.00%) | 0.03% | $0 M | Nov 13, 2026 |
| 48 | Barclays PLC | 31,840 | +13,351 (+72.21%) | 0.03% | $0 M | Nov 6, 2026 |
| 49 | Police & Firemen's Retirement System of New Jersey | 30,684 | 0 (0.00%) | 0.03% | $0 M | Nov 9, 2026 |
| 50 | Parallel Advisors, LLC | 27,326 | 0 (0.00%) | 0.02% | $0 M | Nov 3, 2026 |
| 51 | Wells Fargo & Company/mn | 26,372 | -47,620 (-64.36%) | 0.02% | $0 M | Nov 16, 2026 |
| 52 | Virtu Financial LLC | 24,279 | New | 0.02% | $0 M | Nov 17, 2026 |
| 53 | Osaic Holdings, Inc. | 21,227 | +4,245 (+25.00%) | 0.02% | $0 M | Nov 12, 2026 |
| 54 | Vanguard Global Advisers, LLC | 20,883 | +385 (+1.88%) | 0.02% | $0 M | Nov 13, 2026 |
| 55 | Knollwood Investment Advisory, LLC | 20,000 | 0 (0.00%) | 0.02% | $0 M | Nov 13, 2026 |
| 56 | BNP Paribas Financial Markets | 18,871 | +6,632 (+54.19%) | 0.02% | $0 M | Nov 12, 2026 |
| 57 | Royal Bank Of Canada | 18,574 | +16,017 (+626.40%) | 0.02% | $0 M | Nov 16, 2026 |
| 58 | New York State Common Retirement Fund | 17,400 | 0 (0.00%) | 0.02% | $0 M | Nov 17, 2026 |
| 59 | Strs Ohio | 15,300 | 0 (0.00%) | 0.01% | $0 M | Oct 30, 2026 |
| 60 | Alliancebernstein L.P. | 14,800 | 0 (0.00%) | 0.01% | $0 M | Nov 16, 2026 |
| 61 | Colton Groome Financial Advisors, LLC | 14,247 | New | 0.01% | $0 M | Oct 6, 2026 |
| 62 | Tower Research Capital LLC (TRC) | 13,528 | +8,702 (+180.31%) | 0.01% | $0 M | Nov 16, 2026 |
| 63 | Commonwealth Equity Services, LLC | 13,410 | +1,500 (+12.59%) | 0.01% | $0 M | Nov 2, 2026 |
| 64 | LPL Financial LLC | 12,525 | -19,275 (-60.61%) | 0.01% | $0 M | Nov 6, 2026 |
| 65 | Prudential Financial Inc | 11,260 | 0 (0.00%) | 0.01% | $0 M | Nov 16, 2026 |
| 66 | UNIVEST FINANCIAL Corp | 10,752 | 0 (0.00%) | 0.01% | $0 M | Nov 5, 2026 |
| 67 | Pathstone Holdings, LLC | 10,013 | New | 0.01% | $0 M | Nov 13, 2026 |
| 68 | 49 Wealth Management, LLC | 10,000 | New | 0.01% | $0 M | Nov 13, 2026 |
| 69 | Legal & General Group Plc | 7,636 | 0 (0.00%) | 0.01% | $0 M | Nov 16, 2026 |
| 70 | Ameritas Investment Partners, Inc. | 7,105 | 0 (0.00%) | 0.01% | $0 M | Nov 13, 2026 |
| 71 | Caz Investments LP | 5,000 | 0 (0.00%) | 0.00% | $0 M | Nov 16, 2026 |
| 72 | Citigroup Inc | 3,883 | -52,514 (-93.11%) | 0.00% | $0 M | Nov 4, 2026 |
| 73 | Simplex Trading, LLC | 3,079 | -8,597 (-73.63%) | 0.00% | $0 M | Nov 4, 2026 |
| 74 | Birchbrook, Inc. | 3,000 | 0 (0.00%) | 0.00% | $0 M | Oct 14, 2026 |
| 75 | Sterling Capital Management LLC | 2,568 | +2,293 (+833.82%) | 0.00% | $0 M | Oct 22, 2026 |
| 76 | GAMMA Investing LLC | 1,860 | New | 0.00% | $0 M | Oct 8, 2026 |
| 77 | MTM Investment Management, LLC | 500 | 0 (0.00%) | 0.00% | $0 M | Oct 30, 2026 |
| 78 | Allworth Financial LP | 475 | New | 0.00% | $0 M | Nov 17, 2026 |
| 79 | SJS Investment Consulting Inc. | 401 | New | 0.00% | $0 M | Oct 26, 2026 |
| 80 | FMR LLC | 391 | -86 (-18.03%) | 0.00% | $0 M | Nov 10, 2026 |
| 81 | Jones Financial Companies Lllp | 109 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
| 82 | Farther Finance Advisors, LLC | 91 | New | 0.00% | $0 M | Oct 8, 2026 |
| 83 | Arax Advisory Partners | 77 | New | 0.00% | $0 M | Nov 12, 2026 |
| 84 | EverSource Wealth Advisors, LLC | 49 | New | 0.00% | $0 M | Nov 4, 2026 |
| 85 | IFP Advisors, Inc | 7 | New | 0.00% | $0 M | Oct 16, 2026 |
| 86 | Essential Partners LLC | 4 | New | 0.00% | $0 M | Oct 14, 2026 |
| 87 | Caitong International Asset Management Co., Ltd | 1 | New | 0.00% | $0 M | Oct 29, 2026 |
Mutual funds holding Hyperfine, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 2.34 M | $3 M | 2.3% | <0.01% | +0.4% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 1.69 M | $2 M | 1.7% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 939,686 | $1 M | 0.93% | <0.01% | −8.1% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 735,193 | $1 M | 0.72% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 848,193 | $1 M | 0.84% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 432,145 | $1 M | 0.43% | <0.01% | +4.3% | May 31, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 261,866 | $0 M | 0.26% | 0.02% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 136,110 | $0 M | 0.13% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 146,339 | $0 M | 0.14% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 121,907 | $0 M | 0.12% | <0.01% | +12% | May 31, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 190,235 | $0 M | 0.19% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC | 97,800 | $0 M | 0.10% | 0.09% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 81,169 | $0 M | 0.08% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC | 116,920 | $0 M | 0.12% | 0.01% | new | Jul 31, 2026 |
| 🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC | 72,580 | $0 M | 0.07% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 102,831 | $0 M | 0.10% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 54,041 | $0 M | 0.05% | <0.01% | +20% | May 31, 2026 |
| 🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 60,300 | $0 M | 0.06% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 49,477 | $0 M | 0.05% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 49,514 | $0 M | 0.05% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc. | 40,754 | $0 M | 0.04% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC | 37,411 | $0 M | 0.04% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 21,908 | $0 M | 0.02% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 17,482 | $0 M | 0.02% | 0.01% | new | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 17,381 | $0 M | 0.02% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 17,209 | $0 M | 0.02% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc. | 12,341 | $0 M | 0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc. | 11,801 | $0 M | 0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 11,698 | $0 M | 0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 10,350 | $0 M | 0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 9,800 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 7,400 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 7,400 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 7,213 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management | 7,105 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC | 9,167 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC | 6,260 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc. | 9,009 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS | 6,943 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC | 5,992 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC | 3,713 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc. | 1,976 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 42 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Hyperfine, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Thomas TeisseyreChief Operating Officer | Sell | -7,345 | $0.850 | — | 671,256 | Form 4 |
| filed | Brett HaleCFO and CAO | Sell | -7,345 | $0.850 | $6 K | 592,420 | Form 4 |
| filed | Brett HaleCFO and CAO | Sell | -6,047 | $1.650 | — | 599,765 | Form 4 |
| filed | Thomas TeisseyreChief Operating Officer | Sell | -6,047 | $1.650 | $10 K | 678,601 | Form 4 |
| filed | Brett HaleCFO and CAO | Grant or award | +330,000 | — | — | 605,812 | Form 4 |
| filed | Maria SainzPresident and CEO, Director | Grant or award | +750,000 | — | — | 789,586 | Form 4 |
| filed | Thomas TeisseyreChief Operating Officer | Grant or award | +330,000 | — | — | 684,648 | Form 4 |
| filed | Thomas TeisseyreChief Operating Officer | Sell | -24,188 | $1.210 | — | 354,648 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Hyperfine, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Fails to deliver
- : 30 shares at $0.73
- : 8,696 shares at $0.85
- : 6,129 shares at $0.87
- : 76,594 shares at $0.89
- : 163 shares at $0.87
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Hyperfine, Inc. scorecard#
Passes 9 of the 22 checks that could be worked out: strongest in growth (4 of 6), weakest in valuation (1 of 5). Fiscal year 2025; market cap of Oct 23, 2026.
Valuation1 of 5
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✓Price to book below its peers' median1.9×Price to book 1.9× against Medical Devices's median of 2.5×.
- ✗Price to sales below its peers' median4.1×Price to sales 4.1× against Medical Devices's median of 2.4×.
- ✗Free cash flow yield above 5%-37.6%Free cash flow is -37.6% of the market value.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth4 of 6
- ✓Revenue grew in the newest year5.2%Revenue up 5.2% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years25.8%25.8% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median25.8%25.8% a year against Medical Devices's median of 10.8% (73 companies).
- ✗Earnings per share grew in the newest year-0.43 vs -0.56Diluted EPS -0.43 in fiscal 2025 against -0.56 the year before (report's currency).
- ✗Net income higher than five years earlier-$36 M-$36 M in fiscal 2025 against -$23 M in 2020.
- ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
Profitability1 of 5
- ✗Profitable in the newest year-$36 MNet income -$36 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-273.4%-273.4% against Medical Devices's median of -8.2% (86 companies).
- ✗Return on equity above 15%-79.0%-79.0% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier-273.4%-273.4% in fiscal 2025 against -1084.7% in 2022.
Financial health3 of 5
- ✓Short-term assets cover short-term liabilities4.3×Current ratio 4.34 at the end of fiscal 2025.
- ✓Debt below equity0.0×Debt to equity 0.00 at the end of fiscal 2025.
- ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $35 M at the end of fiscal 2025.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone-6.22Z-score -6.22 (distress zone) for fiscal 2025.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year12.9%Diluted shares up 12.9% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Hyperfine, Inc.'s statements, beside the median of Medical Devices.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -273.5% | -8.2% | |
| Net margin | -262.3% | -10.4% | |
| Return on equity | -79.0% | -16.8% | |
| Revenue growth, 3 years a year | 25.8% | 10.8% | |
| Revenue growth | 5.2% | 10.4% | |
| Debt to equity | 0.00× | 0.64× |
4of 8on the Piotroski tests of financial strength
- Net loss of $36 million, the 6th loss-making year in a row.
- Free cash flow was negative: -$29 million.
- The share count rose 12.9% in the year.
- Revenue has grown 5 years in a row.
Hyperfine, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 14+5.2%100% | 13+16.8%100% | 11+61.9%100% | 6.8+355%100% | 1.5+409%100% | 0.3—100% | |
| Cost of revenue | 6.8−2.7%50.2% | 7.0+11.5%54.3% | 6.3+6.2%56.9% | 5.9+122%86.7% | 2.7+245%178% | 0.8—262% | |
| Gross profit | 6.8+14.6%49.8% | 5.9+23.8%45.7% | 4.8+424%43.1% | 0.9—13.3% | −1.2—−78.0% | −0.5—−162% | |
| Research and development | 17−22.4%129% | 22+0.0%175% | 22−20.1%204% | 28+9.0%413% | 26+77.1%1727% | 15—4964% | |
| Selling and marketing | 10+11.1%74.7% | 9.1−9.7%70.8% | 10−28.9%91.6% | 14+37.2%209% | 10+314%693% | 2.5—850% | |
| General and administrative | 16−7.1%120% | 17−13.7%136% | 20−37.4%184% | 32+17.9%476% | 27+364%1838% | 5.9—2014% | |
| Operating expenses | 44−10.7%323% | 49−7.1%381% | 53−29.3%479% | 75+17.4%1097% | 64+177%4258% | 23—7828% | |
| Operating income | −37—−273% | −43—−335% | −48—−436% | −74—−1084% | −65—−4336% | −23—−7990% | |
| Interest and finance income | 1.0−58.9%7.5% | 2.5−35.1%19.3% | 3.8+405%34.8% | 0.8+4128%11.2% | 0.0−74.3%1.2% | 0.1—23.8% | |
| Other non-operating income (expense) | −0.3−2908%−2.5% | 0.0−65.7%0.1% | 0.0—0.3% | −0.1—−0.7% | −0.0—−0.1% | −0.0—−2.0% | |
| Income before tax | −36—−262% | −41—−316% | −44—−401% | −73—−1074% | −65—−4335% | −23—−7968% | |
| Income tax | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | — | |
| Net income including minority interests | −36—−262% | −41—−316% | −44—−401% | −73—−1074% | −65—−4335% | −23—−7968% | |
| Net income attributable to shareholders | −36—−262% | −41—−316% | −44—−401% | −44r−73—−649% | −65—−4335% | −23—−7968% | |
| Earnings per share, basic | -0.43—— | -0.56—— | -0.62—— | -1.04—— | -17.57—— | -15.38—— | |
| Earnings per share, diluted | -0.43—— | -0.56—— | -0.62—— | -1.04—— | -17.57—— | -15.38—— | |
| Shares, weighted average (basic) | 82+13.0%— | 72+1.5%— | 71+1.2%— | 70+1809%— | 3.7—— | — | |
| Shares, weighted average (diluted) | 82+13.0%— | 72+1.5%— | 71+1.2%— | 70+1809%— | 3.7+142%— | 1.5—— | |
| Balance sheet | |||||||
| Cash and cash equivalents | 35−6.8%63.5% | 38−49.9%63.9% | 75−36.0%79.8% | 117−37.7%87.6% | 188+201%93.1% | 63—87.6% | |
| Receivables | 5.3−11.8%9.5% | 6.0+86.8%10.1% | 3.2+51.6%3.4% | 2.1+280%1.6% | 0.6+218%0.3% | 0.2—0.2% | |
| Inventory | 7.1+21.6%12.8% | 5.8−11.4%9.9% | 6.6+42.4%7.0% | 4.6+7.2%3.4% | 4.3+151%2.1% | 1.7—2.4% | |
| Other current assets | 1.3−33.9%2.3% | 1.9−20.5%3.2% | 2.4−25.1%2.5% | 3.2+135%2.4% | 1.4+96.4%0.7% | 0.7—1.0% | |
| Current assets | 51−5.2%92.1% | 54−39.6%91.2% | 89−30.9%94.4% | 129−34.8%96.0% | 197+189%97.5% | 68—95.5% | |
| Property, plant and equipment | 2.5−18.4%4.6% | 3.1+4.1%5.3% | 3.0−7.7%3.2% | 3.2−13.5%2.4% | 3.8+97.1%1.9% | 1.9—2.7% | |
| Right-of-use (leased) assets | 0.3−7.3%0.6% | 0.3+42.7%0.6% | 0.2—0.3% | — | — | — | |
| Total assets | 55−6.2%100% | 59−37.5%100% | 94−29.7%100% | 134−33.8%100% | 202+183%100% | 72r0.3—100% | |
| Accounts payable | 4.1+152%7.3% | 1.6+32.4%2.7% | 1.2+79.1%1.3% | 0.7−69.8%0.5% | 2.2+137%1.1% | 0.9—1.3% | |
| Current liabilities | 12+34.4%21.2% | 8.7−0.4%14.8% | 8.8−0.4%9.3% | 8.8−44.1%6.6% | 16+282%7.8% | 4.1r0.3—5.8% | |
| Long-term debt | 0—0.0% | — | — | — | — | — | |
| Lease liabilities (non-current) | 0.1−15.4%0.1% | 0.1+21.9%0.1% | 0.1—0.1% | — | — | — | |
| Total liabilities | 14+44.6%25.8% | 9.9+0.6%16.7% | 9.8−5.1%10.4% | 10−36.4%7.7% | 16+278%8.0% | 4.3r0.3—6.0% | |
| Retained earnings | −330—−597% | −294—−500% | −254—−269% | −209—−156% | −136—−67.3% | −71r−0.0—−99.9% | |
| Shareholders' equity | 41−16.4%74.2% | 49−41.9%83.3% | 84−31.8%89.6% | 124−33.6%92.3% | 186—92.0% | −61r0.0—−85.4% | |
| Total liabilities and equity | 55−6.2%100% | 59−37.5%100% | 94−29.7%100% | 134−33.8%100% | 202+183%100% | 72r0.3—100% | |
| Cash-flow statement | |||||||
| Depreciation and amortization | — | — | — | 1.0+39.8%14.9% | 0.7+151%48.5% | 0.3—98.3% | |
| Share-based compensation | 2.8−35.8%20.7% | 4.4−8.0%33.8% | 4.7−55.5%43.0% | 11+54.4%156% | 6.9+518%461% | 1.1—380% | |
| Cash from operating activities | −28—−206% | −39—−301% | −42—−379% | −72—−1062% | −47—−3154% | −22—−7321% | |
| Capital expenditure | −1.2—−8.7% | −0.4—−3.0% | −0.8—−7.3% | −0.6—−8.6% | −2.7—−181% | −1.6—−533% | |
| Cash from investing activities | −1.2—−8.7% | −0.4—−3.0% | −0.8—−7.3% | −0.6—−8.6% | −2.7—−181% | −1.6—−533% | |
| Cash from financing activities | 28+2599%203% | 1.0+486%7.9% | 0.2+2386%1.6% | 0.0−100.0%0.1% | 177+190%11816% | 61—20727% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 19+80.0%100% | 6.0+73.4%100% | 3.9+44.8%100% | 3.9+82.6%100% | 5.3*+128%100% | 3.4−5.7%100% | 2.7−25.8%100% | 2.1−35.1%100% | 2.3*−13.6%100% | 3.6—100% | 3.6—100% | 3.3—100% | 2.7*—100% | |
| Cost of revenue | 9.0+58.2%47.4% | 2.6+62.2%43.3% | 1.9+40.6%49.3% | 1.9+53.4%49.3% | 2.6*+73.8%49.1% | 1.6−8.4%46.2% | 1.4−25.2%50.7% | 1.3−35.4%58.7% | 1.5*−9.5%64.4% | 1.7—47.6% | 1.8—50.3% | 1.9—58.9% | 1.7*—61.5% | |
| Gross profit | 10+105%52.6% | 3.4+83.0%56.7% | 2.0+49.1%50.7% | 2.0+124%50.7% | 2.7*+226%50.9% | 1.8−3.1%53.8% | 1.3−26.3%49.3% | 0.9−34.8%41.3% | 0.8*−20.1%35.6% | 1.9—52.4% | 1.8—49.7% | 1.4—41.1% | 1.0*—38.5% | |
| Research and development | 15−17.5%81.0% | 3.9−3.3%65.7% | 3.9−14.9%99.0% | 3.8−23.7%98.5% | 3.8*−25.1%72.3% | 4.0−31.0%118% | 4.5−23.8%168% | 5.0−9.6%236% | 5.1*−14.4%220% | 5.9—161% | 6.0—164% | 5.6—169% | 6.0*—222% | |
| Selling and marketing | 10+4.3%54.7% | 2.7+4.2%44.9% | 2.7+6.1%68.6% | 2.6+0.9%65.6% | 2.5*+6.4%47.3% | 2.6+2.9%74.7% | 2.5+11.2%93.6% | 2.5+26.7%119% | 2.4*−6.9%101% | 2.5—68.5% | 2.3—62.5% | 2.0—60.8% | 2.5*—94.1% | |
| General and administrative | 16−1.4%84.6% | 4.1−2.4%68.0% | 3.9+1.2%100% | 4.1−1.9%106% | 4.0*−2.4%76.2% | 4.2−7.9%121% | 3.9−12.7%143% | 4.2−5.0%197% | 4.1*−1.0%178% | 4.5—124% | 4.4—122% | 4.4—134% | 4.2*—155% | |
| Operating expenses | 42−6.8%220% | 11−1.2%179% | 10−4.3%268% | 11−10.6%270% | 10*−10.6%196% | 11−16.3%313% | 11−13.6%405% | 12−1.8%551% | 12*−8.5%499% | 13—353% | 13—348% | 12—364% | 13*—471% | |
| Operating income | −32—−168% | −7.3—−122% | −8.5—−217% | −8.6—−219% | −7.7*—−145% | −8.9—−260% | −9.6—−356% | −11—−510% | −11*—−464% | −11—−301% | −11—−299% | −11—−323% | −12*—−433% | |
| Interest and finance income | 1.1−7.0%5.8% | 0.3+55.6%4.9% | 0.3+13.8%7.0% | 0.3−19.9%6.5% | 0.3*−35.8%5.3% | 0.2−68.0%5.4% | 0.2−64.6%8.9% | 0.3−60.2%14.8% | 0.4*−52.7%18.8% | 0.6—16.1% | 0.7—18.6% | 0.8—24.2% | 0.9*—34.3% | |
| Interest expense and finance costs | — | 0.5—9.2% | 0.5—13.7% | 0.1—2.1% | — | 0—0.0% | 0—0.0% | 0—0.0% | — | — | — | — | — | |
| Other non-operating income (expense) | 0.0—0.2% | 0.0+5.9%0.3% | 0.0−96.5%0.1% | 0.0—0.1% | 0.0*—0.2% | 0.0−67.3%0.5% | 0.1+467%3.2% | −0.5−7617%−21.1% | −0.1*−365%−2.6% | 0.1—1.4% | 0.0—0.4% | 0.0—0.2% | 0.0*—0.9% | |
| Income before tax | −30—−156% | −6.0—−100% | −9.3—−238% | −8.6—−221% | −5.9*—−112% | −11—−321% | −9.2—−342% | −9.4—−441% | −10*—−448% | −10—−283% | −10—−280% | −9.8—−299% | −11*—−398% | |
| Income tax | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0*—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0*—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0*—0.0% | |
| Net income including minority interests | −30—−156% | −6.0*—−100% | −9.3*—−238% | −8.6—−221% | −5.9*—−112% | −11*—−321% | −9.2*—−342% | −9.4—−441% | −10*—−448% | −10*—−283% | −10*—−280% | −9.8—−299% | −11*—−398% | |
| Net income attributable to shareholders | −30—−156% | −6.0—−100% | −9.3—−238% | −8.6—−221% | −5.9*—−112% | −11—−321% | −9.2—−342% | −9.4—−441% | −10*—−448% | −10—−283% | −10—−280% | −9.8—−299% | −11*—−398% | |
| Earnings per share, basic | — | -0.06—— | -0.09—— | -0.09—— | — | -0.14—— | -0.12—— | -0.12—— | — | -0.14—— | -0.14—— | -0.14—— | — | |
| Earnings per share, diluted | — | -0.06—— | -0.09—— | -0.09—— | — | -0.14—— | -0.12—— | -0.12—— | — | -0.14—— | -0.14—— | -0.14—— | — | |
| Shares, weighted average (basic) | 106+34.3%— | 106+34.3%— | 100+27.8%— | 98+29.1%— | — | 79+8.7%— | 78+8.4%— | 76+5.2%— | — | 73—— | 72—— | 72—— | — | |
| Shares, weighted average (diluted) | 106+34.3%— | 106+34.3%— | 100+27.8%— | 98+29.1%— | — | 79+8.7%— | 78+8.4%— | 76+5.2%— | — | 73—— | 72—— | 72—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 38—65.5% | 38+75.6%65.5% | 43+71.0%69.0% | 41+23.2%67.6% | 35−6.8%63.5% | 22−52.9%51.9% | 25−52.8%56.2% | 33−47.6%62.0% | 38−49.9%63.9% | 46—66.0% | 54—70.2% | 63—74.0% | 75—79.8% | |
| Receivables | 5.2—9.0% | 5.2+6.0%9.0% | 4.2−16.6%6.7% | 3.8−28.9%6.3% | 5.3−11.8%9.5% | 4.9−28.1%11.8% | 5.1−5.8%11.2% | 5.3−0.2%10.0% | 6.0+86.8%10.1% | 6.8—9.8% | 5.4—7.0% | 5.3—6.3% | 3.2—3.4% | |
| Inventory | 6.4—11.0% | 6.4+9.2%11.0% | 6.8+39.1%10.8% | 6.3+36.4%10.5% | 7.1+21.6%12.8% | 5.8−17.1%14.1% | 4.9−34.6%10.8% | 4.6−36.4%8.7% | 5.8−11.4%9.9% | 7.0—10.2% | 7.5—9.7% | 7.3—8.5% | 6.6—7.0% | |
| Other current assets | 2.2—3.9% | 2.2−18.3%3.9% | 1.9−29.3%3.0% | 2.6−11.2%4.4% | 1.3−33.9%2.3% | 2.7+36.2%6.6% | 2.7+18.8%5.9% | 3.0+0.4%5.6% | 1.9−20.5%3.2% | 2.0—2.9% | 2.3—3.0% | 3.0—3.5% | 2.4—2.5% | |
| Current assets | 54—93.0% | 54+45.7%93.0% | 59+47.7%94.0% | 56+15.8%92.9% | 51−5.2%92.1% | 37−42.4%88.9% | 40−43.5%88.6% | 48−39.3%90.7% | 54−39.6%91.2% | 64—92.4% | 71—92.7% | 80—93.3% | 89—94.4% | |
| Property, plant and equipment | 2.1—3.6% | 2.1−23.7%3.6% | 2.3−27.5%3.6% | 2.5−19.1%4.1% | 2.5−18.4%4.6% | 2.7−12.2%6.6% | 3.1−9.0%6.9% | 3.1−16.5%5.8% | 3.1+4.1%5.3% | 3.1—4.5% | 3.4—4.5% | 3.7—4.3% | 3.0—3.2% | |
| Right-of-use (leased) assets | 0.7—1.3% | 0.7+295%1.3% | 0.2−29.9%0.3% | 0.2−11.8%0.4% | 0.3−7.3%0.6% | 0.2+77.1%0.4% | 0.3+70.5%0.6% | 0.3+44.3%0.5% | 0.3+42.7%0.6% | 0.1—0.2% | 0.1—0.2% | 0.2—0.2% | 0.2—0.3% | |
| Total assets | 58—100% | 58+39.2%100% | 63+39.3%100% | 60+13.0%100% | 55−6.2%100% | 42−40.2%100% | 45−41.0%100% | 53−37.5%100% | 59−37.5%100% | 69—100% | 77—100% | 85—100% | 94—100% | |
| Accounts payable | 1.7—2.9% | 1.7−54.4%2.9% | 2.4−18.5%3.8% | 4.6+97.5%7.5% | 4.1+152%7.3% | 3.7+164%8.9% | 3.0+32.8%6.6% | 2.3−9.0%4.3% | 1.6+32.4%2.7% | 1.4—2.0% | 2.2—2.9% | 2.5—3.0% | 1.2—1.3% | |
| Debt due within a year | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | — | — | — | — | — | — | — | — | — | |
| Current liabilities | 11—18.2% | 11+3.6%18.2% | 9.6+20.5%15.3% | 10+27.3%16.8% | 12+34.4%21.2% | 10+2.1%24.5% | 8.0−9.1%17.7% | 8.0−9.0%14.9% | 8.7−0.4%14.8% | 10.0—14.4% | 8.8—11.5% | 8.8—10.3% | 8.8—9.3% | |
| Long-term debt | 13—23.1% | 13—23.1% | 13—21.0% | 13—21.7% | 0—0.0% | — | — | — | — | — | — | — | — | |
| Lease liabilities (non-current) | 0.3—0.5% | 0.3—0.5% | 0−100%0.0% | 0.0+6.3%0.0% | 0.1−15.4%0.1% | 0—0.0% | 0.0—0.0% | 0.0−5.9%0.0% | 0.1+21.9%0.1% | — | — | 0.0—0.0% | 0.1—0.1% | |
| Total liabilities | 26—45.1% | 26+77.9%45.1% | 26+160%41.7% | 26+153%43.1% | 14+44.6%25.8% | 15+32.3%35.3% | 10+2.6%22.3% | 10+4.7%19.2% | 9.9+0.6%16.7% | 11—15.9% | 9.8—12.9% | 9.8—11.5% | 9.8—10.4% | |
| Retained earnings | −354—−612% | −354—−612% | −348—−552% | −339—−561% | −330—−597% | −324—−781% | −313—−692% | −304—−569% | −294—−500% | −284—−409% | −274—−357% | −264—−308% | −254—−269% | |
| Shareholders' equity | 32—54.9% | 32+18.1%54.9% | 37+4.6%58.3% | 34−20.3%56.9% | 41−16.4%74.2% | 27−53.9%64.7% | 35−47.4%77.7% | 43−43.0%80.8% | 49−41.9%83.3% | 58—84.1% | 67—87.1% | 76—88.5% | 84—89.6% | |
| Total liabilities and equity | 58—100% | 58+39.2%100% | 63+39.3%100% | 60+13.0%100% | 55−6.2%100% | 42−40.2%100% | 45−41.0%100% | 53−37.5%100% | 59−37.5%100% | 69—100% | 77—100% | 85—100% | 94—100% | |
| Cash-flow statement | ||||||||||||||
| Share-based compensation | 3.2+1.3%16.8% | 1.0+55.9%16.1% | 0.9+65.1%23.1% | 0.6−31.5%16.6% | 0.7*−34.3%13.1% | 0.6−44.0%18.0% | 0.5−53.4%20.3% | 0.9−8.4%44.2% | 1.1*−18.2%45.4% | 1.1—30.2% | 1.2—32.3% | 1.0—31.3% | 1.3*—48.0% | |
| Cash from operating activities | −28—−145% | −6.1*—−102% | −7.3*—−186% | −9.0—−231% | −5.2*—−98.4% | −5.6*—−162% | −7.9*—−293% | −9.2—−433% | −8.4*—−360% | −8.5*—−234% | −9.4*—−258% | −13—−380% | −9.9*—−370% | |
| Capital expenditure | −0.4—−1.9% | −0.0*—−0.4% | −0.0*—−0.8% | −0.2—−6.2% | −0.1*—−1.2% | −0.1*—−3.8% | −0.5*—−19.3% | −0.5—−22.1% | −0.0*—−0.3% | −0.2*—−4.4% | −0.1*—−2.0% | −0.1—−4.4% | −0.3*—−9.6% | |
| Cash from investing activities | −0.4—−1.9% | −0.0*—−0.4% | −0.0*—−0.8% | −0.2—−6.2% | −0.1*—−1.2% | −0.1*—−3.8% | −0.5*—−19.3% | −0.5—−22.1% | −0.0*—−0.3% | −0.2*—−4.4% | −0.1*—−2.0% | −0.1—−4.4% | −0.3*—−9.6% | |
| Cash from financing activities | 45+438%234% | −0.0*−100%−0.2% | 11*+2175%276% | 14+160%371% | 19*+35607%364% | 2.2*+154%63.0% | 0.5*+703%17.6% | 5.6+10049%261% | 0.1*+92.9%2.3% | 0.9*—23.4% | 0.1*—1.6% | 0.1—1.7% | 0.0*—1.0% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Hyperfine, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- Device(total)$11 M84%+9.1%
- Service(total)$2 M16%-11%
Countries and regions
- Non-US(total)$3 M23%-51%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Events at Hyperfine, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
Delisting notice 3 · Restructuring 1 · Directors and officers 1 · Material agreement 4 · New debt 1 · Unregistered share sale 1 · Bylaws or fiscal year changed 1 · Shareholder vote 3 · Results announced 14
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Results announced | 8-K | |
| Delisting notice | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreementNew debtUnregistered share sale | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Delisting notice | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Restructuring | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Bylaws or fiscal year changedShareholder vote | 8-K | |
| Delisting notice | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 9, 2026
H-1B hiring at Hyperfine, Inc.#
1 labor condition applications certified in fiscal 2026 for 1 positions, at a median wage of $201 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Fellow, Electrical EngineerElectrical Engineers | 1 | $201 K |
Where: Guilford, CT 1
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 1 | 1 | $201 K | 1 |
| FY2025 | 3 | 3 | $197 K | 3 |
| FY2024 | 2 | 2 | — | 2 |
| FY2023 | 2 | 2 | $172 K | 2 |
| FY2022 | 4 | 4 | $173 K | 4 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Hyperfine, Inc.
From US state WARN notices and SEC 8-K restructuring filings, newest first.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | · | · | · | · | · | · | · | · | · | · | · | · | — |
| 2022 | · | · | · | · | · | · | · | · | · | · | · | · | — |
| Announced | People | Kind | Where | Source |
|---|---|---|---|---|
| 14% of workforce | Restructuring planSEC 8-K | “As a result, the Company has terminated approximately 14% of its global workforce.” | Filing | |
| 13% of workforce | Restructuring planSEC 8-K | “As a result, the Company has terminated approximately 13% of its global workforce including, among others, the employees of its subsidiary, Liminal Sciences, Inc.” | Filing |
Source: State WARN notices and SEC 8-K item 2.05
How Hyperfine, Inc. compares in Medical Devices
- Market cap$78 M · higher than 33% of 142
- Revenue$14 M · higher than 19% of 155
- Net margin-156.6% · higher than 10% of 144
- Revenue growth5.2% · higher than 35% of 104
- Price / sales4.1× · lower than 38% of 96
- Price / book1.9× · lower than 63% of 99
- FCF yield-37.6% · higher than 20% of 76
Peer comparison · Medical Devices
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Hyperfine, Inc.🇺🇸 | $78 M | — | -156.6% | +5.2% |
| Abbott Laboratories🇺🇸 | $181.1 B | 38.5× | 9.8% | +5.7% |
| Medtronic plc🇺🇸 | $121.2 B | 23.2× | 13.9% | +8.4% |
| Stryker Corporation🇺🇸 | $116.5 B | 32.2× | 13.8% | +11.2% |
| Boston Scientific Corporation🇺🇸 | $66.2 B | 18.9× | 16.6% | +19.9% |
| Edwards Lifesciences Corporation🇺🇸 | $52.8 B | 51.7× | 15.3% | +11.6% |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳 | $27.8 B | 23.6× | 24.4% | — |
| STERIS plc🇮🇪 | $20.4 B | 24.6× | 13.4% | +8.7% |
| Zimmer Biomet Holdings, Inc.🇺🇸 | $18.2 B | 23.8× | 8.9% | +7.2% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Apex Medical$75 M
- Outset Medical, Inc.$82 M
- Pulmonx Corporation$86 M
- Nano-X Imaging Ltd.$70 M
- Applied BioCode Corporation$68 M
- Neuraxis, Inc.$95 M
Sources and freshness
- Market cap:
- Oct 23, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As of February 15, 2026
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Hyperfine, Inc.? Verify and update this profile — free
Show Hyperfine, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.